Scholarlink

Background <p>Interstitial lung disease (ILD) commonly presents with exertional dyspnea and hypoxemia, exercise intolerance, widespread tiredness, cough, distress, and/or anxiety, significantly impairing health-related quality of life (HRQoL). Pulmonary rehabilitation (PR) is an alternative therapeutic strategy that may successfully reduce the physical limitations and symptom load associated with (ILD). Increasing evidence suggests that PR should be an essential element in the therapy of ILD.</p> Aim <p>To analyze the outcome of short-term PR on patients with ILD with and without pulmonary hypertension (PH).</p> Methodology <p>This prospective interventional study was executed in Chest and Rheumatology, Rehabilitation and Physical Medicine Departments, Faculty of Medicine, Tanta University Hospitals, from January 2020 to January 2023. Eighty ILD patients enrolled in the present study and were assessed for association of pulmonary hypertension by transthoracic echocardiographic examination and were subdivided into four equal groups: Group I: it consisted of 20 ILD patients on their usual medical treatment only. Group II: it included 20 ILD patients submitted to PR program in addition to their medical treatment. Group Ш: it included 20 ILD patients with pulmonary hypertension on their usual medical treatment. Group IV: it included 20 ILD patients with pulmonary hypertension submitted to pulmonary rehabilitation program in addition to their usual medical treatment. PR program was applied for 8&#xa0;weeks (2 sessions weekly) and each session consisted of aerobic exercise program, strength/resistance training for the upper and lower body, breathing exercises, and patient health education.</p> Results <p>This research represented a statistically significant improvement for the PR groups over the control groups at the completion of the PR program in PFTS (FEV<sub>1</sub>%, FVC%, FEV<sub>1</sub>/FVC%, and MVV%), ABG parameters (paCO<sub>2</sub>, paO<sub>2</sub>, and SaO<sub>2</sub>), dyspnea by mMRC, exercise tolerance by 6MWT, leg strength by 30&#xa0;s chair stand test, and quality of life by SGRQ total score.</p> Conclusion <p>ILDs patients with and without PH may benefit from PR, an adjuvant treatment that can enhance lung function, reduce the perception of dyspnea, increase exercise tolerance, leg strength, and HRQOL.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月19日

查看全文
  • Mona Abd Elsalam Taha El Gazzar,
  • Wafaa Saleh El Shimy,
  • Hanan Mohamed Elsaadany,
  • Mohamed Sayed Hantera,
  • Basem Ibrahim Elshafey

摘要

Background

Interstitial lung disease (ILD) commonly presents with exertional dyspnea and hypoxemia, exercise intolerance, widespread tiredness, cough, distress, and/or anxiety, significantly impairing health-related quality of life (HRQoL). Pulmonary rehabilitation (PR) is an alternative therapeutic strategy that may successfully reduce the physical limitations and symptom load associated with (ILD). Increasing evidence suggests that PR should be an essential element in the therapy of ILD.

Aim

To analyze the outcome of short-term PR on patients with ILD with and without pulmonary hypertension (PH).

Methodology

This prospective interventional study was executed in Chest and Rheumatology, Rehabilitation and Physical Medicine Departments, Faculty of Medicine, Tanta University Hospitals, from January 2020 to January 2023. Eighty ILD patients enrolled in the present study and were assessed for association of pulmonary hypertension by transthoracic echocardiographic examination and were subdivided into four equal groups: Group I: it consisted of 20 ILD patients on their usual medical treatment only. Group II: it included 20 ILD patients submitted to PR program in addition to their medical treatment. Group Ш: it included 20 ILD patients with pulmonary hypertension on their usual medical treatment. Group IV: it included 20 ILD patients with pulmonary hypertension submitted to pulmonary rehabilitation program in addition to their usual medical treatment. PR program was applied for 8 weeks (2 sessions weekly) and each session consisted of aerobic exercise program, strength/resistance training for the upper and lower body, breathing exercises, and patient health education.

Results

This research represented a statistically significant improvement for the PR groups over the control groups at the completion of the PR program in PFTS (FEV1%, FVC%, FEV1/FVC%, and MVV%), ABG parameters (paCO2, paO2, and SaO2), dyspnea by mMRC, exercise tolerance by 6MWT, leg strength by 30 s chair stand test, and quality of life by SGRQ total score.

Conclusion

ILDs patients with and without PH may benefit from PR, an adjuvant treatment that can enhance lung function, reduce the perception of dyspnea, increase exercise tolerance, leg strength, and HRQOL.